Sciatic nerve of diabetic rat treated with epoetin delta: Effects on c-fibers and blood vessels including pericytes

Angiology

Volumn 61, Issue 7, 2010, Pages 651-668

  Loesch, Andrzej ^a   Tang, Helen ^a   Cotter, Mary A ^b   Cameron, Norman E ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

diabetes; electron immunocytochemistry; epoetin; rat; sciatic nerve

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CD131 ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; RECOMBINANT ERYTHROPOIETIN; TYROSINE 3 MONOOXYGENASE; ERYTHROPOIETIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY LABELING; ARTICLE; AUTONOMIC NERVE; BLOOD VESSEL; DIABETES MELLITUS; IMMUNOREACTIVITY; MALE; MICROVASCULATURE; NONHUMAN; PERICYTE; RAT; SCIATIC NERVE; VASCULAR ENDOTHELIUM; ANIMAL; BLOOD FLOW; CYTOLOGY; DIABETIC NEUROPATHY; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; IMMUNOHISTOCHEMISTRY; METABOLISM; NERVE CONDUCTION; NONMYELINATED NERVE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CYTOKINE RECEPTOR COMMON BETA SUBUNIT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; ERYTHROPOIETIN; IMMUNOHISTOCHEMISTRY; MALE; MICROVESSELS; NERVE FIBERS, UNMYELINATED; NEURAL CONDUCTION; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; PERICYTES; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; REGIONAL BLOOD FLOW; SCIATIC NERVE;

EID: 77956488689     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319709360030     Document Type: Article

References (85)

1. Cameron NE, Cotter MA, Ferguson K., Robertson S., Radcliffe MA Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats. Diabetes. 1991 ; 40 (12). 1652-1658.
2. Cameron NE, Gibson TM, Nangle MR, Cotter MA Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes. Ann NY Acad Sci. 2005 ; 1043: 784-792.
3. Brewster WJ, Diemel LT, Leach RM, Tomlinson DR Reduced sciatic nerve substance P and calcitonin gene-related peptide in rats with short-term diabetes or central hypoxaemia co-exist with normal messenger RNA levels in the lumbar dorsal root ganglia. Neuroscience. 1994 ; 58 (2). 323-330.
4. Diemel LT, Brewster WJ, Fernyhough P., et al. Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain derived neurotrophic factor. Brain Res Mol Brain Res. 1994 ; 21 (1-2). 171-175.
5. Fernyhough P., Diemel LT, Brewster WJ, et al. Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: effects of insulin treatment. Neuroscience. 1994 ; 62 (2). 337-344.
6. Cotter MA, Cameron NE Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. Life Sci. 2003 ; 73 (14). 1813-1824.
7. Amenta F., Mione MC, Napoleone P. The autonomic innervation of the vasa vasorum. J Neural Transm. 1983 ; 58 (3-4). 291-297.
8. Appenzeller O., Dhital KK, Cowen T., et al. The nerves of blood vessels supplying blood to nerves: the innervation of vasa nervorum. Brain Res. 1984 ; 304 (2). 383-386.
9. Dhital K., Lincoln J., Appenzeller O., et al. Adrenergic innervation and nervi nervorum of optic, sciatic, vagus and sympathetic nerve trunks of normal and streptozotocin-diabetic rats. Brain Res. 1986 ; 367 (1-2). 39-44.
10. Dhital K., Appenzeller O. Innervation of vasa nervorum. In: Burnstock G, Griffith SG, eds. Nonadrenergic Innervation of Blood Vessels. Vol II. Boca Raton, FL: CRC Press ; 1988: 191-211.
11. Milner P., Appenzeller O., Qualls C., et al. Differential vulnerability of neuropeptides in nerves of the vasa nervorum to streptozotocin-induced diabetes. Brain Res. 1992 ; 574 (1-2). 56-62.
12. Ii M., Nishimura H., Kusano, KF, et al. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy. Circulation. 2005 ; 112 (1). 93-102.
13. Moncada S., Palmer, RMJ, Higgs EA Nitric oxide: physiology, pathology, and pharmacology. Pharmacol Rev. 1991 ; 43 (2). 109-142.
14. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994 ; 298 (pt 2). 149-158.
15. Lincoln J., Hoyle CHV, Burnstock G. Nitric Oxide in Health and Disease. Lucy JA, ed. Cambridge UK: Cambridge University Press ; 1997.
16. Nangle MR, Gibson TM, Cotter MA, et al. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats. Planta Med. 2006 ; 72 (6). 494-500.
17. Rubany GM Endothelium-derived vasoactive factors in health and disease. In: Rubanyi GM, ed. Cardiovascular Significance of Endothelium-Derived Vasoactive Factors. Mount Kisco, NY: Futura ; 1991: xi - xix.
18. Nangle MR, Cotter MA, Cameron NE Alteration of aortic function from streptozotocin-diabetic rats with Kilhamĝs virus is associated with inducible nitric oxide synthase. Vet J. 2006 ; 172 (3). 455-459.
19. Yorek MA, Coppey LJ, Gellett JS, et al. Sensory nerve innervation of epineurial arterioles of the sciatic nerve containing calcitonin gene-related peptide: effect of streptozotocin-induced diabetes. Exp Diabesity Res. 2004 ; 5 (3). 187-193.
20. Ochoa J. Microscopic anatomy of unmyelinated nerve fibers. In: Dyck PJ, Thomas PK, Lambert EH, eds. Peripheral Neuropathy. Vol 1, Philadelphia: W B Saunders ; 1975: 131-150.
21. Ochoa J. Structure and function of the peripheral nervous system. 2 nd ed. Philadelphia: Williams & Wilkins ; 1980: 73-90.
22. Carlsen F., Behse F. Three dimensional analysis of Schwann cells associated with unmyelinated nerve fibers in human sural nerve. J Anat. 1980 ; 130 (pt 3). 545-557.
23. Murinson BB, Griffin JW C-fiber structure varies with location in peripheral nerve. J Neuropathol Exp Neurol. 2004 ; 63 (3). 246-254.
24. Murinson BB, Hoffman PN, Banihashemi MR, et al. C-fiber (Remak) bundles contain both isolectin B4-binding and calcitonin gene-related peptide-positive axons. J Comp Neurol. 2005 ; 484 (4). 392-402.
25. Gerbi A., Maixent JM, Ansaldi JL, et al. Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats. J Nutr. 1999 ; 129 (1). 207-213.
26. Cameron NE, Cotter MA Epoetin delta corrects nerve blood flow and function in diabetic rats: relevance for vascular complications and neuropathy. Nephrol Dialysis Transplant Plus. 2008 ; 1 (suppl 2). ii11.
27. Loesch A., Tang H., Cotter MA, et al. The endothelium of basilar artery of diabetic rat treated with epoetin delta. Angiology. 2009: Oct 8. [Epub ahead of print].
28. Ghezzi P., Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ. 2004 ; 11 (suppl 1). S37S44.
29. Buemi M., Aloisi C., Cavallaro E. et al. Recombinant human erythropoietin (rHuEPO): more than just the correction of uremic anemia. J Nephrol. 2002 ; 15 (2). 97-103.
30. Fisher JW Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood). 2003 ; 228 (1). 1-14.
31. Leist M., Ghezzi P., Grasso G., et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science. 2004 ; 305 (5681). 239-242.
32. Brines M., Cerami A. Discovering erythropoietinĝs extrahematopoietic functions: biology and clinical promise. Kidney Int. 2006 ; 70 (2). 246-250.
33. Jubinsky PT, Krijanovski OI, Nathan DG, et al. The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood. 1997 ; 90 (5). 1867-1873.
34. Blake TJ, Jenkins BJ, DĝAndrea RJ, et al. Functional cross-talk between cytokine receptors revealed by activating mutations in the extracellular domain of the beta-subunit of the GM-CSF receptor. J Leukoc Biol. 2002 ; 72 (6). 1246-1255.
35. Mueller RA, Thoenen H., Axelrod J. Increase in tyrosine hydroxylase activity after reserpine administration. J Pharmacol Exp Therap. 1969 ; 169 (1). 74-79.
36. Pickel VM, Joh TH, Reis DJ Ultrastructural localisation of tyrosine hydroxylase in noradrenergic neurons of the brain. Proc Natl Acad Sci USA. 1975 ; 72 (2). 659-663.
37. Cameron NE, Cotter MA Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of the polyol pathway. Diabetologia. 1992 ; 35 (11). 1011-1019.
38. Gundersen HJ, Jensen EB, KiÖu K., et al. The efficiency of systematic sampling in stereology-reconsidered. J Microsc. 1999 ; 193 (Pt 3). 199-211.
39. Small JR, Scadding JW, Landon DN A fluorescence study of changes in noradrenergic sympathetic fibers in experimental peripheral nerve neuromas. J Neurol Sci. 1990 ; 100 (1-2). 98-107.
40. Small JR, Scadding JW, Landon DN Ultrastructural localization of sympathetic axons in experimental rat sciatic nerve neuromas. J Neurocytol. 1996 ; 25 (10). 573-582.
41. Griffin JW, Thompson WJ Biology and pathology of nonmyelinating Schwann cells. Glia. 2008 ; 56 (14). 1518-1531.
42. Wang ZY, DahlstrÖm A. Axonal transport of zinc transporter 3 and zinc containing organelles in the rodent adrenergic system. Neurochem Res. 2008 ; 33 (12). 2472-2479.
43. Brines M., Grasso G., Fiordaliso F., et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci USA. 2004 ; 101 (41). 14907-14912.
44. Levitt M., Spector S., Sjoerdsma A., et al. Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guinea-pig heart. J Pharmacol Exp Ther. 1965 ; 148: 1-8.
45. Geffen LB, Livett BG Synaptic vesicles in sympathetic neurons. Physiol Rev. 1971 ; 51 (1). 98-157.
46. Belai A., Lincoln J., Milner P., et al. Progressive changes in adrenergic, serotonergic and peptidergic nerves in proximal colon of streptozotocin-diabetic rats. Gastroenterology. 1988 ; 95 (5). 1234-1241.
47. Calore EE, Cavaliere MJ, Puga FR, et al. Histologic peripheral nerve changes in rats induced by eltamethrin1. Ecotoxicol Environ Saf. 2000 ; 47 (1). 82-86.
48. Dahl D., Chi NH, Miles LE, Nguyen BT, Bignami A. Glial fibrillary acidic (GFA) protein in Schwann cells: fact or artifact ? J Histochem Cytochem. 1982 ; 30 (9). 912-918.
49. Triolo D., Dina G., Lorenzetti I., et al. Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage. J Cell Sci. 2006 ; 119 (19). 3981-3993.
50. Hu W., Gu J., Deng A., et al. Polyglycolic acid filaments guide Schwann cell migration in vitro and in vivo. Biotechnol Lett. 2008 ; 30 (11). 1937-1942.
51. Wolfe DE, Potter ILT, Richardson KC, et al. Localising tritiated norepinephrine in sympathetic axons by electron microscope autoradiography. Science. 1962 ; 138 (3538). 440-442.
52. Tranzer JP, Thoenen H., Snipes RL, Richards JG Recent developments on the ultrastructural aspect of adrenergic nerve endings in various experimental conditions. Progr Brain Res. 1969 ; 31: 33-46.
53. Morris JH, Hudson AR, Weddell G. A study of degeneration and degeneration in the divided rat sciatic nerve based on electron microscopy. Parts I-IV. Z Zellforsch Mikrosk Anat. 1972 ; 124 (1-2). 76-203.
54. Pellieter G., Leclerc R., Puviani R., Polak JM Electron immunocytochemistry of vasoactive intestinal peptide (VIP) in the rat brain. Brain Res. 1981 ; 210 (1-2). 356-360.
55. Priestley JV Pre-embedding ultrastructural immunocytochemistry: immunoenzyme techniques. In: Polak J, Varandell I, eds. Immunolabeling for Electron Microscopy. Amsterdam UK, Elsevier-North Holland ; 1984: 37-52.
56. Burnstock G. Cotransmission. In: Squire LR, ed. Encyclopedia of Neuroscience. vol 3. Oxford, UK: Academic Press ; 2009: 247-254.
57. GonzÖlez-HernÖndez T., Rustioni A. Expression of three forms of nitric oxide synthase in peripheral nerve regeneration. J Neurosci Res. 1999 ; 55 (2). 198-207.
58. Liu W., Hirata K., Kawabuchi M. The occurrence of nitric oxide synthase-containing axonal baskets surrounding large neurons in rat dorsal root ganglia after sciatic nerve ligation. Arch Histol Cytol. 2005 ; 68 (1). 29-40.
59. Bergman E., Carlsson K., Liljeborg A., Manders E., HÖkfelt T., Ulfhake B. Neuropeptides, nitric oxide synthase and GAP-43 in B4-binding and RT97 immunoreactive primary sensory neurons: normal distribution pattern and changes after peripheral nerve transection and aging. Brain Res. 1999 ; 832 (1-2). 53-83.
60. GonzÖlez-HernÖndez T., Rustioni A. Nitric oxide synthase and growth-associated protein are coexpressed in primary sensory neurons after peripheral injury. J Comp Neurol. 1999 ; 404 (1). 64-74.
61. Qi WN, Yan ZQ, Whang PG, et al. Gene and protein expressions of nitric oxide synthases in ischemia-reperfused peripheral nerve of the rat. Am J Physiol Cell Physiol. 2001 ; 281 (3). C849 - C856.
62. Lee Y., Shin T. Expression of constitutive endothelial and inducible nitric oxide synthase in the sciatic nerve of Lewis rats with experimental autoimmune neuritis. J Neuroimmunol. 2002 ; 126 (1-2). 78-85.
63. Toth CC, Willis D., Twiss JL, et al. Locally synthesized calcitonin gene-related peptide has a critical role in peripheral nerve regeneration. J Neuropathol Exp Neurol. 2009 ; 68 (3). 326-337.
64. Kissin I., Freitas CF, Mulhern HL, DeGirolami U. Sciatic nerve block with resiniferatoxin: an electron microscopic study of unmyelinated fibers in the rat. Anesth Analg. 2007 ; 105 (3). 825-831.
65. Belai A., Lincoln J., Milner P., Crowe R., Loesch A., Burnstock G. Enteric nerves in diabetic rats: increase in vasoactive intestinal polypeptide but not substance P. Gastroenterology. 1985 ; 89 (5). 967-976.
66. Semra YK, Wang M., Peat NJ, et al. Selective susceptibility of different populations of sympathetic nerves to diabetic neuropathy in vivo is reflected by increased vulnerability to oxidative stress in vitro. Neurosci Lett. 2006 ; 407 (3). 199-204.
67. Shotton HR, Lincoln J. Diabetes only affects nitric oxide synthase-containing myenteric neurons that do not contain heme oxygenase. Brain Res. 2006 ; 1068 (1). 248-256.
68. Baddeley AJ, Gundersen HJG, Cruz-Orive LM Estimation of surface area from vertical sections. J Microsc. 1986 ; 142 (pt 3). 259-276.
69. Bell MA, Weddell AG A descriptive study of the blood vessels of the sciatic nerve in the rat, man and others. Brain. 1984 ; 107 (pt 3). 871-898.
70. Bell MA, Weddell AG A morphometric study of intrafascicular vessels of mammalian sciatic nerve. Muscle Nerve. 1984 ; 7 (7). 524-534.
71. Lundborg G. Ischemic nerve injury. Experimental studies on intraneural microvascular pathophysiology and nerve function in a limb subjected to temporary circulatory arrest. Scan J Plast Reconstr Surg Suppl. 1970 ; 6: 3-113.
72. Lundborg G. The intrinsic vascularization of human peripheral nerves: structure and functional aspects. J Hand Surg. 1979 ; 4 (1). 34-41.
73. Olsson Y. Vascular permeability in the peripheral nervous system. In: Dyck PJ, Thomas PK, Lambert EH, eds. Peripheral Neuropathy. Philadelphia, PA: Saunders; 1975: 190-200.
74. SjÖstrandt J., Rydevik B., Lundborg G., et al. Impairment off intraneural microcirculation, blood-nerve barrier and axonal transport in experimental nerve ischemia and compression. In: Korr IM, ed. The Neurobiologic Mechanisms in Manipulative Therapy. New York, USA: Plenum Press ; 1977: 337-358.
75. Peppiatt CM, Howarth C., Mobbs P., Attwell D. Bidirectional control of CNS capillary diameter by pericytes. Nature. 2006 ; 443 (7112). 700-704.
76. Vareniuk I., Pavlov IA, Obrosova IG Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes. Diabetologia. 2008 ; 51 (11). 2126-2133.
77. Cameron NE, Tuck Z., McCabe L., et al. Effects of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion and function in experimental diabetes. Diabetologia. 2001 ; 44 (9). 1161-1169.
78. Nangle MR, Cotter MA, Cameron NE. Effects of the peroxynitrite decomposition catalyst, FeTMPyP, on function of corpus cavernosum from diabetic mice. Eur J Pharmacol. 2004 ; 502 (1-2). 143-148.
79. Obrosova IG, Drel VR, Oltman CL, et al. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am J Physiol. 2007 ; 293 (6). E1645 - E1655.
80. Kanda T. Therapeutic strategy for peripheral nerve regeneration; molecular control at the blood-nerve barrier. Rinsho Shinkeigaku. 2008 ; 48 (11). 1028-1030.
81. Shimizu F., Sano Y., Maeda T., et al. Peripheral nerve pericytes originating from the blood-nerve barrier expresses tight junctional molecules and transporters as barrier-forming cells. J Cell Physiol. 2008 ; 217 (2). 388-399.
82. Alnaeb ME, Thompson CS, Seifalian AM, et al. Regional differences in the expression of nitric oxide synthase and specific receptors in the vascular tissues of control and diabetic rabbits: a pilot study. In Vivo. 2007 ; 21 (6). 1069-1074.
83. Estrella JS, Nelson RN, Sturges BK, et al. Endoneurial microvascular pathology in feline diabetic neuropathy. Microvasc Res. 2008 ; 75 (3). 403-410.
84. Jeong JO, Kim MO, Kim H., et al. Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation. 2009 ; 119 (5). 699-708.
85. Prokopi M., Pula G., Mayr U., et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood. 2009 ; 114 (3). 723-732.